Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Device VC (Venture Capital) Funds in Italy in December 2024

Last updated: Dec 2024 A list of 50 VC (Venture Capital) funds that invest in Medical device startups based in Italy. We rank investors based on the number of investments they made in Medical device companies from Italy. We update this investor list every month.

Top 50 Medical Device VC (Venture Capital) Funds in Italy in December 2024

Investor	Medical Device Italy investments
CDP Venture Capital	7
Italian Angels for Growth	6
Principia SGR	5
Innogest Capital	5
A11 Venture	4
Eureka Venture	3
Invitalia Ventures	2
LIFTT	2
Atlante Ventures	2
Intesa Sanpaolo	2
Panakes Partners	2
Healthware Ventures	2
Vertis	2
UniCredit	2
Club degli Investitori	1
Fondazione Cottino	1
GM&C Life Sciences Fund	1
Growth Engine	1
Fountain Healthcare Partners	1
Rancilio Cube	1
F3F	1
RoboIT	1
Si14	1
Sistema Investimenti	1
RedSeed Ventures	1
EASME - EU Executive Agency for SMEs	1
SFEM Italia	1
INGENIUM Emilia Romagna	1
Sviluppo Imprese Centro Italia	1
Italian Angels for Biotech	1
Andera Partners	1
Toscana Next Fund	1
UV-Cap	1
Estor	1
Amazon Alexa Fund	1
Bios Line Holding	1
I.A.C.E.R. srl	1
Equiter	1
Deep Blue Ventures	1
Avanzi Etica Sicaf EuVECA	1
Embed Capital	1
Indaco Venture Partners	1
Spindial Group	1
Cysero	1
Omnes Capital	1
Green Arrow Capital	1
Lazio Innova	1
Fondazione Golinelli	1
Manilo Marocco Partners	1
Roca X	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Funding Round
Italy, United States, Germany

Portfolio highlights

Waxy — Waxy is an innovative startup that operates in the domain of designing, building, and distributing technologies for the sanitization of liquids and food products.
Tau Group — E-mobility is powered by its core - the electric motor. We at Tau are at the very core of the core: the copper winding wire, the magnetic core, the electrical steel.We just make it bet.
Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.

IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.

Investment focus

Software, E-Commerce, Health Care
Seed, Angel, Series A
Italy, United States, United Kingdom

Portfolio highlights

ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
Rubedo Life Sciences — Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.
Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.

Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.

Investment focus

Health Care, Biotechnology, Software
Funding Round, Series A, Seed
Italy, United States, United Kingdom

Portfolio highlights

KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.

We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries

Investment focus

Health Care, Medical, Medical Device
Funding Round, Series A, Series B
Italy, United States, Spain

Portfolio highlights

GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.

A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi: scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.

Investment focus

Biotechnology, Medical Device, Health Care
Seed, Pre-Seed, Series A
Italy, United States

Portfolio highlights

Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.

Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments

Investment focus

Nanotechnology, Renewable Energy, Medical Device
Funding Round, Seed, Pre-Seed
Italy

Portfolio highlights

Planckian — Charging the future by powering energy with science We explore frontiers of energy science by developing quantum...
INTA Systems — Nanotech and artificial intelligence for biomolecular analysis
BeDimensional — We produce graphene and others two-dimensional materials (2D) with few atomic layers. Find out more.

Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it

Investment focus

Software, Medical, Health Care
Series A, Funding Round, Seed
Italy, United States, United Kingdom

Portfolio highlights

Ecomate — The ESG Rating platform for every company
BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.

A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.

Investment focus

Biotechnology, Software, Information Technology
Seed, Series A, Funding Round
Italy, United Kingdom, France

Portfolio highlights

Evoralis — Utilise Our Innovative Enzymes to Efficiently Recycle Plastics Into High-Quality Raw Materials
MicroLub — MicroLub produces a fat replacement for lower-calorie plant-based diets. It is cutting-edge innovation to the next generation of protein technology, creating exclusive ingredient solutions that significantly minimize molecular friction.
Composite Research — CoRe Research is an start-up, aimed at the study of new product and process solutions in the field of composite materials.

Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.

Investment focus

Software, Biotechnology, Hardware
Funding Round, Seed, Series A
Italy, United States, Israel

Portfolio highlights

treet — Treet helps brands launch fully-branded recommerce sites where customers can buy & sell items from each other.
Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.

Intesa Sanpaolo is a banking group that specializes in wealth management, protection, advisory, and digital orientation. Their products and services include accounts, cards, loans, mortgages, insurance, digital payments, retirement planning, investments, and consulting.

Investment focus

Financial Services, FinTech, Renewable Energy
Debt Financing, Post-IPO Debt, Series A
Italy, United Kingdom, United States

Portfolio highlights

La Doria — La Doria is a producer and sells tomato derivatives, ready sauces, preserved legumes, fruit juices, and beverage products. They offer products that include boiled legumes, baked beans, red kidney beans, carrots, ready-made soups and stews, and canned pasta in tomato sauce.
MODIFI — Explore digital trade finance and B2B payment solutions that empower your business to grow globally.
Maire Tecnimont — We are enablers of innovation, working alongside businesses to develop sustainable technologies and design integrated solutions that inspire energy transition.

Panakes Partners is a venture capital investor that finances in medical companies, startups, and high growth SMEs in Europe and Israel. Advantages of the firm are broad network of business contacts and corporate relations, domain expertise, proactive portfolio management, and relationship with selected industrial partners. Investments of thecompany focus on medical devices, diagnostics, biotech for in-vitro diagnostics, IT healthcare, and medical services.Panakes Partners is an Italy-based company that was founded in 2015 by Alessio Beverina, Fabrizio Landi, and Diana Saraceni.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
Italy, Ireland, Switzerland

Portfolio highlights

Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
SamanTree Medical — SamanTree Medical has developed the Histolog Scanner, a confocal microscopy device intended for imaging the surface of excised human tissue specimens to visualize morphological microstructures. Easy-to-read images are available immediately, providing decision-making support at the point of care.
CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

Healthware Ventures is the corporate venture capital arm of Healthware Group

Investment focus

Health Care, Personal Health, PaaS
Seed, Pre-Seed, Series A
Italy, Austria, United States

Portfolio highlights

PatchAi — Improve patient engagement and experience in clinical trials and standard care. Discover Patchai solution.
1000Farmacie — 1000Farmacie is the leading Pharmacy Marketplace in Italy. Though a network of independent Pharmacies we deliver faster!
YourCoach Health — Health and Wellness coach practice management solution enabling coaches to holistically lead their clients, connecting mind, body and soul through behavior modification and accountability tools towards outcomes

Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.

Investment focus

Software, E-Commerce, Computer
Seed, Funding Round, Series A
Italy, United States

Portfolio highlights

Aindo — Unlock the full potential of your data. The power of synthetic data integrated in a comprehensive Data Platform.
Radical Storage — Find your closest luggage storage and enjoy your journey until the very end!
Starting Finance — Starting Finance is a financial education platform intended to provide financial literacy to its users. The company's platform provides education and information about finance and publishes informative articles on important events in the fields of economics, finance, and politics, enabling users to improve their knowledge regarding finance andthe management of their capital.

UniCredit (formerly UniCredito) is an Italian global banking and financial services company. Its network spanning 50 markets in 20 countries, with more than 9,000 branches and over 148,000 employees. Its strategic position in Western and Eastern Europe gives the group one of the region's highest market shares.

Investment focus

Energy, Manufacturing, Financial Services
Debt Financing, Post-IPO Debt, Funding Round
Italy, Germany, Sweden

Portfolio highlights

La Doria — La Doria is a producer and sells tomato derivatives, ready sauces, preserved legumes, fruit juices, and beverage products. They offer products that include boiled legumes, baked beans, red kidney beans, carrots, ready-made soups and stews, and canned pasta in tomato sauce.
Unifiber — Unifiber is a broadband service company that focuses on the creation of passive access fiber optic networks.
ambrogio transporti — ambrogio transporti is a intermodal transportation company.

Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.

Investment focus

Health Care, E-Commerce, Information Technology
Seed, Series A, Series B
Italy, Switzerland, United Kingdom

Portfolio highlights

Ephos — Designing and manufacturing glass-based integrated photonic circuits that power the most advanced classical and quantum devices
Stema — It serves as a platform for hiring engineers
Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.

Fondazione Cottino is support young people in their educational path and support for scientific research, technology transfer.

Investment focus

Medical, mHealth, Diabetes
Seed
Italy

Portfolio highlights

D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Investment focus

Health Care, Biotechnology, Medical
Seed, Funding Round, Series A
United Kingdom, Italy, Germany

Portfolio highlights

ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.

Growth Engine is a holding company that invests in startups and scaleups with high growth potential founded by Fabio Mondini de Focatiis, Andrea Marangione, Michele Appendino and Marco Ariello, Venture Capital professionals with an excellent track record. Growth Engine invests in Italian startups at the Pre-Seed and Seed stage.

Investment focus

E-Commerce, Information Technology, Software
Seed, Secondary Market, Pre-Seed
Italy, Mexico, United Kingdom

Portfolio highlights

Cubbit — Cubbit is secure encrypted cloud storage with a difference. A distributed cloud that is 100% private and green. Join the Swarm.
StarTric — StarTric developes and is taken to clinical use as a transcatheter structural heart implantable device. They are developing a unique transcatheter repair implantable device to treat TR. They manage entrance to the right atrium, reducing the flow to the lungs. They offer heart failure, atrial fibrillation, and other morbidities.
TrueScreen — Certify photo, video, screenshot, document and audio recording with legal value. Prevent fraud and disputes obtaining indisputable evidences

Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Series C
Ireland, United States, France

Portfolio highlights

MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
Mainstay Medical — Mainstay Medical is improving quality of life for patients with chronic low back pain through innovative restorative treatment medical device solutions.
Ermium Therapeutics — Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation.Ermium Therapeutics was founded in June 2019 by Jean-Philippe HERBEUVAL, Kurma Partners, Idinvest Partners, Domain Therapeutics and Erganeo. The company isbased in Paris and has signed a worldwide exclusive license agreement on intellectual property from CNRS and University Paris Descartes (France) through an agreement with Erganeo, which supported the maturation of the project in an academic setting. In addition, Ermium Therapeutics recently won the innovation i-Lab 2019 award from the French Ministry of Research and Higher Education.

Cube is the investment office founded by Rancilio family

Investment focus

E-Commerce, Software, Financial Services
Seed, Series A, Series B
United States, Italy, Germany

Portfolio highlights

Convoy — Using technology and automation, the Convoy Platform seamlessly connects carriers with loads from shippers and brokers across the nation.
FinCompare - Smarter Business Finance — FinCompare was founded by Stephan Heller and is a fintech startup that helps businesses to find, compare, and close the financing solutions. Via the online platform, companies can access a wide range of financing options. They can independently compare offers from well-known banks, fintechs, and alternative financial services providers in Germanyand close the financing. The company also offers a convenient one-stop destination for all financing questions relating to the company.FinCompare financing solutions including corporate loan, factoring, company leasing/hire purchase, warehouse financing, fine trading/purchase financing, and mezzanine capital. It simplifies the financing process with its digital application process and can thus provide your company financing. The company allows SMEs to receive and compare various offers for loans.FinCompare was founded in October 2016 by Stephan Heller and is headquartered in Berlin, Germany.
Finom — Finom is an online payment solution for entrepreneurs that makes it easy to open a business account and securely manage their finances.

F3F

Investment focus

Hardware, Hospital, Software
Series A, Series C
Italy

Portfolio highlights

Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.

RoboIT is the National Technology Transfer Hub for Robotics and Industrial Automation.

Investment focus

Medical, Manufacturing, Medical Device
Pre-Seed
Italy

Portfolio highlights

J4Energy — We are the next-generation Digital Energy Platform, delivering the industrial energy transition from strategy to execution.
Eye2Drive — EYE2DRIVE is a young company designing and building a new imaging sensor for the autonomous cars. We are based in Tuscany, Italy.
Fluid Wire Robotics — Fluid Wire Robotics sets the new standard for robots in harsh environments. We design innovative robotic arms that excel in radioactive, explosive, space, and subsea applications, avoiding the complexity and cost of traditional solutions. Our technology ensures unparalleled safety, reliability, and efficiency, redefining robot design for any challenging environment without performance loss. Discover our groundbreaking approach and robust, versatile solutions.

Si14 is a visionary original design and development laboratory for novel technology products that enhance the way we live, work and play. Founded in 2008 and based in Padova, Italy, Si14 turns inspiration into the realization of compelling, cutting-edge products and services that help people connect with their activities and their world, empowerenterprises in realizing greater efficiencies, improve access to vital health screening services for millions worldwide, and much more.

Investment focus

Medical, mHealth, Diabetes
Seed
Italy

Portfolio highlights

D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.

Sistema Investimenti is an holding in the form of SpA, established by the will of young professionals and entrepreneurs in Sicily. Sistema Investimenti focus on qualified minorities primarily in companies in the South of Italy with the exception of turnaround/restructuring and distressed.

Investment focus

Mobile, Medical, Health Care
Seed
Italy

Portfolio highlights

Pedius — Pedius is a communication system that allows deaf people to make normal phone calls. Use it in your everyday life to make important calls such as booking doctors appointments or making reservations, or to call family, friends and coworkers.Once you download the smartphone app you can start a conversation by either typing or speaking a message.The recipient will listen on their end and reply, and you will immediately read a transcription of what he or she just said. Pedius gives you the freedom to have real-time conversations when you need to call a plumber, book a table at your favourite restaurant, or talk to your doctor.The Pedius app is especially useful when you need to contact someone accessible only by phone, and it is an excellent help when you need to be careful about your privacy.
Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.

RedSeed Ventures is a Venture Capital firm investing in Early Stage Companies and Scaleups, in Europe and more particularly in Italy.

Investment focus

Retail, Crowdsourcing, Information Technology
Seed, Series A
Italy, United Kingdom

Portfolio highlights

Dianax — Milan-based Dianax was founded in 2013 starting from a group scientists led by Eugenio Iannone and Maurizio Moroni and by a few angel investors orchestrated by Gabriele Bavagnoli. Dianax mission is to develop and manufacture labs-on-chip aiming to trasform protein-based diagnostics and make it prompt, easy to use, inexpensive and reliableTheDianax novel technology is designed to make precise diagnostic results convenient, easily accessible, and affordable to patients and healthcare professionals, to empower them to effective prevention, ongoing accurate management and timely emergency treatment.The Dianax technology is the first ever application to diagnostics of a combination of microfluidic innovations and electrochemistry detection systems.Dianax was founded by Eugenio Iannone and his partners to pursue technical and market opportunities based on proprietary, independent research.
Leaf Space — Leaf Space offers a global network of ground stations, providing seamless, cost-effective satellite communication with scalable solutions for all mission sizes.
WIB Machines — Smart vending machines and smart lockers manufacturer pioneering smart, web-based retail automation globally. Patented solutions enabling next-gen retail.

Executive Agency for SMEs

Investment focus

Biotechnology, Health Care, Software
Grant, Seed, Funding Round
Spain, United Kingdom, Switzerland

Portfolio highlights

AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.

SFEM Italia is a family office that chooses, manages, and oversees the investments of the Stevanato Family. SFEM is dedicated to the management of all non-core investments for the group including alternative investments such as real estate, private equity, and venture capital. It was founded in 2012 and is headquartered in Milan, Italy.

Investment focus

Big Data, Health Care, Medical Device
Seed
Italy

Portfolio highlights

PatchAi — Improve patient engagement and experience in clinical trials and standard care. Discover Patchai solution.

INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.

Investment focus

Medical, Health Care, Privacy
Seed, Angel, Funding Round
Italy

Portfolio highlights

CellPly — Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing theability to monitor the clinical response to these treatments.Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.
GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.

Sviluppo Imprese Centro Italia is an independent asset management company founded in Florence in 1998. Active in the Private Equity and Venture Capital sector, it currently manages four closed-end funds for a total value of around 140 million euro and has already carried out numerous operations. in the capital of companies operating in variousindustrial sectors, from the most traditional to high-tech. The mission of SICI is to encourage the development of unlisted SMEs in Central Italy through the contribution of financial resources intended to strengthen their capital and financial structure. SICI intends to represent a Growth Partner for the investee companies and a strategic operator in the creation of value for the territory with an impact on the economic and social fabric in terms of competitiveness of the economic system, employment, entrepreneurial and managerial culture. Business Development Central Italy is an independent Italian managing closed-end funds company. Established in Florence in 1998, SICI has 4 Private Equity and Venture funds under management with a total committed capital of 140m Euros.

Investment focus

Software, Travel, Semiconductor
Seed, Angel, Pre-Seed
Italy

Portfolio highlights

Cents — Cents is a platform that allows businesses to raise awareness in the market by supporting social and environmental causes.
Parking My Car — Parking My Car offers transportation services.
Recuperiamo srl — Recuperiamo srl is a food industry founded to prevent and reduce waste throughout the food chain. They are involved in the food industry through the Regusto brand. They can use geolocation to report on last-minute offers for their dishes.

Angel group focuses on biotech

Investment focus

Health Care, Biotechnology, Pharmaceutical
Seed
Italy

Portfolio highlights

MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
CaSRevolution — A novel disease-modifying approach against neurodegeneration
Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Investment focus

Biotechnology, Health Care, Medical
Series B, Private Equity, Funding Round
France, United States, Germany

Portfolio highlights

Qovoltis — Qovoltis specializes in the renewable energy sector, providing smart charging solutions for electric vehicles. Their product is a smart charger with real-time power demand adaptability, designed to connect with all vehicles compatible with the ISO 15118 standard. The company also offers a mobile application that allows users to authenticatethemselves and manage their charging remotely. In addition to individual users, Qovoltis provides innovative charging station solutions for real estate projects, enhancing asset value.
Skysun — Skysun is a financial institution that provides financial solutions and services to the solar energy sector.
Kestra Medical Technologies, Inc. — Kestra Medical Technologies is a wearable medical device and digital healthcare company that protects patients with diagnostic and therapeutic technologies that are intuitive, and mobile. They provide intuitive medical technologies to protect and support at-risk patients.

Toscana Next Fund is a co-investment fund managed by CDP Venture Capital.

Investment focus

Medical, Manufacturing, Medical Device
Pre-Seed
Italy

Portfolio highlights

Eye2Drive — EYE2DRIVE is a young company designing and building a new imaging sensor for the autonomous cars. We are based in Tuscany, Italy.
Soundsafe Care — Soundsafe care combines robotics and focused ultrasound to establish a new way to perform surgical care.

UV-Cap is a German family office that invests in mid-size cooperations that have great potential in their markets in the "b-to-b" business. It is based in Ravensburg, Germany.

Investment focus

Personal Health, Big Data, Wellness
Seed, Series A
Italy, Germany

Portfolio highlights

PatchAi — Improve patient engagement and experience in clinical trials and standard care. Discover Patchai solution.
Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.

Estor is a Investment Firm.

Investment focus

Health Care, Biotechnology, Medical Device
Seed
Italy

Portfolio highlights

Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.

The Amazon Alexa Fund is Amazon’s venture capital fund investing in artificial intelligence, frontier tech, voice, robotics, and digital health across consumer and enterprise. We invest in early- to growth-stage companies globally. To learn more, visit us at alexafund.com.

Investment focus

Software, Artificial Intelligence, Machine Learning
Seed, Series A, Series B
United States, United Kingdom, Canada

Portfolio highlights

Heeyo — Talking AIs that helps kids learn and play!
Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Imbue — We want machines that learn the way humans do.Our mission is to build human-like general intelligence and make it safely accessible in order to foster a more abundant, equitable, and unconstrained society.We take a first-principles approach, starting from simple self-supervised architectures and evolving them to tackle human developmentalmilestones of increasing complexity.

investment firm

Investment focus

Sports, Leisure, E-Commerce
Seed
Italy

Portfolio highlights

MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
Freedome — Freedome is the leading marketplace for outdoor activities in Italy

Manufacturer of medical devices for home rehabilitation

Investment focus

Wellness, Health Care, Medical Device
Seed
Italy

Portfolio highlights

Euleria Health — Devices and technologies for more accessible and measurable rehabilitation and telerehabilitation at the service of clinics and movement experts, in the clinic and at home.

Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.

Investment focus

Medical, Health Care, Information Technology
Seed, Series B, Convertible Note
Italy

Portfolio highlights

AWorld — AWorld is The Sustainability Platform and Mobile App chosen by the United Nations to support the ActNow Campaign.
Medics — 3D anatomical modeling per la pianificazione pre-operatoria e il supporto intra-operatorio delle chirurgie complesse.
BionIT Labs — We apply IT to Bionics in order to Turn disabilities into New Possibilities

DEEP BLUE VENTURES Venture Capital Fund DEEP BLUE VENTURES DBV Deep Blue Ventures is our first Venture Capital fund DBV is an early stage deep tech fund, investing in outstanding deep technologies, and people able to harnessing them to great global success. Deep Blue Ventures

Investment focus

Biotechnology, Medical Device, Artificial Intelligence
Seed
Italy

Portfolio highlights

INTA Systems — Nanotech and artificial intelligence for biomolecular analysis

Avanzi Etica Sicaf EuVECA is an investment company that supports the development and growth of SMEs and innovative startups .

Investment focus

Fashion, Wellness, Recycling
Seed, Series A
Italy

Portfolio highlights

Euleria Health — Devices and technologies for more accessible and measurable rehabilitation and telerehabilitation at the service of clinics and movement experts, in the clinic and at home.
Ricehouse — Ricehouse uses organic residues, such as rice straw, husk and chaff, from the rice industry and creates natural construction materials.
greenchic — A pioneer of the circular economy, greenchic is the number 1 fashion-logistics startup in Southern Europe. Send us what you wish to swap, and immediately start buying with our reward points system. Thanks to this effortless service model, greenchic offers the fastest DTC way to regain value from no longer used clothing. Through greenchic, memberscan exchange items and revamp their style in an affordable, convenient and sustainable way. With 99% of the products sold, reused, upcycled, or donated to charities within 6 months, greenchic is set to become a European leader in circular fashion. With its growing user base, the highest customer retention rate in fashion recommerce, a 4.5-star TrustPilot rating, the platform offers to its highly engaged community a collection of more than 240.000 items. Thanks to a semi-automated logistic warehouse, an event-driven serverless digital platform, and its own digital token, the startup is experiencing a 2X growth pattern and is supported by some of the best investors from the Italian fashion & social impact scene.greenchic is now operating in Italy and France.Find out more by visiting greenchic.com and following @greenchic on socials.

Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.

Investment focus

Information Technology, Health Care, Mobile
Seed, Funding Round, Pre-Seed
Italy, Switzerland, United Kingdom

Portfolio highlights

Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
The Nemesis — The Nemesis is the playground for play-to-earn games and adventures in virtual worlds. Accessible on both mobile and desktop.

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
Italy, Switzerland, United States

Portfolio highlights

D-Orbit — End-to-end services for the New Space industry, including platform engineering, launch and deployment, and decommissioning.
MicThera — MicThera focuses on developing microbial-derived therapeutics to provide effective treatments for prostate cancer patients, aiming to find effective solutions for medical companies.
Genespire — Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.

Spindial Group

Investment focus

Medical, Health Care, Biotechnology
Funding Round
Italy

Portfolio highlights

Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.

Cysero is a venture capital fund focused on the robotics and cybersecurity sectors. The fund was established in October 2020 and managed by AVM Gestioni SGR S.p.A. Manager EuVECA Società Benefit and jointly promoted with Kilometro Rosso, Bergamo's science and technology park.

Investment focus

Mobile, Internet, Robotics
Seed, Funding Round
Italy

Portfolio highlights

Octostar — Octostar objective is to empower investigators by offering the advanced and adaptable intelligence platform.
DataKrypto — The Cloud Encryption Company DataKrypto -
TrueScreen — Certify photo, video, screenshot, document and audio recording with legal value. Prevent fraud and disputes obtaining indisputable evidences

Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.

Investment focus

Biotechnology, Software, Health Care
Series A, Funding Round, Series B
France, Germany, United States

Portfolio highlights

Qantev — Qantev is the leading AI claims platform for health & life insurance, enabling insurers to automate claims operations, reduce leakage, improve loss ratios, enhance data quality, and elevate customer experience.
Carbyon — Carbyon is a Netherlands-based company that develops direct air capture (DAC) technologies. The company's fuels help to replace fossil hydrocarbons with electrical batteries or hydrogen (H2), alternative energy carriers that are used to store renewable electricity and make major changes to transportation facilities, energy grids, and gastransportation networks, filters CO2 from the air and supply it in a purified form to make kerosene for aircraft, enabling existing fossil industry to re-use and repurpose these storage and transport facilities for renewable hydrocarbons.
The Exploration Company — For Space & Non-Space Industries.

Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.

Investment focus

Health Care, Biotechnology, Manufacturing
Funding Round, Seed, Series A
Italy, United Kingdom

Portfolio highlights

Cogisen — Cogisen develops artificial intelligence solutions. It offers SENCOGI, an eye-tracking software for smartphones/mobile phones. Chiara Passacantilli and Christiaan Erik Rijnders founded Cogisen in 2009. Its headquarters is in Naples in Italy.
Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.

Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.

Investment focus

Software, Health Care, Artificial Intelligence
Seed, Pre-Seed, Grant
Italy, United Kingdom

Portfolio highlights

Joinrs — We developed an artificial intelligence model able to read job offers for you and show you the ones that best match your profile.
Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
Ticketoo — Ticketoo: compra e vendi biglietti fan-to-fan in modo sicuro

Fondazione Golinelli was born in Bologna in 1988 by the will of the entrepreneur and philanthropist Marino Golinelli with the aim to promote education and training, to promote the culture, to foster intellectual growth and ethics of young people, the citizens of tomorrow.

Investment focus

FinTech, Financial Services, AgTech
Seed, Pre-Seed
Italy

Portfolio highlights

Biorfarm — Adotta il tuo Albero, crea il tuo Campo Digitale e ricevi a domicilio la tua frutta biologica. Solo con Biorfarm puoi seguire la crescita dei tuoi frutti!
EvenFi — Criptalia uses blockchain technology to connect businesses that have projects to be funded with people and organizations who are looking for high-yield investments. We offer an online platform where companies publish their innovative ideas and industrial improvement projects. Investors, people, and institutions can fund these projects by lendingmoney in exchange for a higher interest rate.
Latitudo40 — Empower sustainable growth with AI-driven satellite insights from Latitudo 40. Unlock precise, real-time data for smarter urban planning, climate risk management, and industry innovation. Enhance resilience and lead with confidence.

Manilo Marocco Partners is an investment firm.

Investment focus

Wellness, Psychology, Health Care
Series A
Italy

Portfolio highlights

Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.

RocaX > Is building a solid and much needed bridge for startups between the support offered by business angels and the upper stage VCs. Learn more!

Investment focus

Software, Information Technology, Health Care
Seed, Pre-Seed, Convertible Note
Romania, Italy, Israel

Portfolio highlights

Milluu — Helping places become homes! Milluu is the app that gets personal, relevant and smart about rent.We believe that things are done properly when you're personally invested. And we invest our technology & smart tools to help you find your next home or your next ideal tenant!We have created a service app that connects directly listers andtenants based on their preferences.Based on AI and ML, our Milluu Bot is the friendly face of the app, assisting you permanently in your rental journey, making suggestions for great matches and helping you close the deal.
Munevo — Munevo empowers people with disabilities by using smart and innovative technology.
Bunnyshell — Bunnyshell is an Environment as a Service platform that enables developers to instantly spin up dev environments for any task on Kubernetes and develop remotely.

Investors by industry

Artificial intelligence